An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022
Sign Up to like & getrecommendations! Published in 2022 at "Molecules"
DOI: 10.3390/molecules27154964
Abstract: Since the early 1980s, phosphodiesterase 4 (PDE4) has been an attractive target for the treatment of inflammation-based diseases. Several scientific advancements, by both academia and pharmaceutical companies, have enabled the identification of many synthetic ligands… read more here.
Keywords: pde4 inhibitors; 2010 early; overview pde4; clinical trials ... See more keywords